A case is presented of a young woman implanted with a program mable implantable medication system (PIMS). Implanted insulin pumps have been the subject of research for over a decade but have encountered a series of obstacles ranging from design problems to insulin aggregation to catheter blocking from omental tissue. Many of these problems, but not all, have been overcome. Implanted insulin pumps are still in a developmental phase. Glucose sensing is not yet available. Nevertheless, PIMS has demonstrated in this case that it can safely and effectively control insulin-dependent diabetes for over 1. 5 years.
Get full access to this article
View all access options for this article.
References
1.
Mecklenburg RS, Sannar CAAcute complications associated with insulin infusion pump therapy: report of experience with 161 patients . JAMA1984;252:3265-69.
2.
Albisser AM, Leibel BS, Ewart TG, et al. Clinical control of diabetes by the artificial pancreas. Diabetes1974;23:397-404.
Clarke, WLThe use of closed-loop insulin delivery systems in diabetes research . In: Clarke WL, Larner J, Pohl SL, eds. Methods in diabetes research. Vol. II. New York: John Wiley & Sons, 1986:361-68.
5.
Buchwald H., Varco RL, Rupp WM, et al. Treatment of a type II diabetic by a totally implantable insulin infusion device. Lancet1981; 1: 1233-37.
6.
Rupp W., Barbosa J., Blackshear P., et al. The use of an implantable insulin pump in the treatment of type II diabetes. N Engl J Med1982;307:265-70.
7.
Blackshear BJ , Shulman GI, Roussel AM, et al. Metabolic response to three years of continuous, basal rate intravenous insulin infusion in type II diabetic patients. J Clin Endocrinol Metab1985;61:753-60.
8.
Buchwald J., Rohde TDImplantable insulin pumps. Chicago: Year Book Medical Publishers, 1984.
9.
Schade DS, Eaton RP, Edwards WS, et al. A remotely programmable insulin delivery system: successful short-term implantation in man. JAMA1982;247:1848-53.
10.
Irsigler K., Kritz H., Hagmüller G., et al. Long-term continuous intraperitoneal insulin infusion with an implantable remote-controlled insulin infusion device. Diabetes1981;30:1072-75.
11.
Selam JL, Slingeneyer A., Chaptal PA, Franetzki M., Prestele K., Mirouze J.Total implantation of a remotely controlled insulin mini-pump in a human insulin dependent diabetic. Artif Organs1982;6:315-19.
12.
Fischell RE, Radford WE, Saudek CDA programmable implantable medication system: application to diabetes . Paper presented at the Sixth Hawaiian Conference on System Sciences , Honolulu, 1983.
13.
Saudek CDDeveloping and assessing an implantable insulin infusion pump: interactions of university, industry, and government. Int J Technol Assess Health Care1986;2:471-82.
14.
Saudek CDDevelopment of implantable insulin infusion devices. In: Clarke WL, Larner J, Pohl SL, eds. Methods in diabetes research . Vol II. New York: John Wiley & Sons, 1986:348-60.
15.
Grau U., Saudek CDStable insulin preparation for implanted insulin pumps: laboratory and animal trials. Diabetes1987;36:1453-59.
Brange J., Havelund S.Insulin pumps and insulin quality—requirements and problems . Acta Med Scand [Suppl] 1983;671:135-38.
18.
Saudek CD, Pitt HA, Dempsey M., et al. The programmable implantable medication system (PIMS): first human implantations. Diabetes1987;36(suppl 1):77A.
19.
Selam JL, Saudek CD, Waxman K., Pitt HA, Fischell RE, Charles MAIntraperitoneal insulin delivery with an implantable programmable pump: 14 patient-years experience with 18 type I diabetic patients. Diabetes1988;37(suppl 1): 83A.
20.
Turner APF, Karube I, Wilson GS, eds. Biosensors: fundamentals and applications. New York: Oxford University Press, 1987.
21.
Pickup JCBiosensors: a clinical perspective. Lancet1985;2:817-20.
